Leanne De Koning (Leanne de Koning)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

Cancers

Oncoimmunology

JCO precision oncology

Current oncology (Toronto, Ont.)

Institut Curie

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut Curie Oct 01 2009

France

Project Manager :: Departement de recherche translationnelle

Publications

Anne Elisabeth Mercier, Annie Margaretha Joubert, Renaud Prudent, Jean Viallet, Agnes Desroches-Castan, Leanne De Koning, Peace Mabeta, Jolene Helena, Michael Sean Pepper, Laurence Lafanechère
Sulfamoylated Estradiol Analogs Targeting the Actin and Microtubule Cytoskeletons Demonstrate Anti-Cancer Properties In Vitro and In Ovo. Cancers 16 (17) (2024)
Fariba Nemati, Leanne De Koning, David Gentien, Franck Assayag, Emilie Henry, Khadija Ait Rais, Gaelle Pierron, Odette Mariani, Michèle Nijnikoff, Gabriel Champenois, André Nicolas, Didier Meseure, Sophie Gardrat, Nicolas Servant, Philippe Hupé, Maud Kamal, Christophe Le Tourneau, Sophie Piperno-Neumann, Manuel J Rodrigues, Sergio Roman-Roman, Didier Decaudin, Pascale Mariani, Nathalie Cassoux
Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study. Current oncology (Toronto, Ont.) 30 (10) (2023)
Stephane Champiat, Hélène Salaün, Francesca Lucibello, Jean Yves Scoazec, Benjamin Besse, Ana Ines Lalanne, Etienne Rouleau, Nolwenn Metzger, Mathilde Saint-Ghislain, Thomas Ryckewaert, Sophie Gardrat, Raymond L Barnhill, Nathalie Cassoux, Marc-Henri Stern, Olivier Lantz, Leanne De Koning, Aurélien Marabelle, Manuel J Rodrigues
Exceptional Response to Dual Colony-Stimulating Factor 1 Receptor/PD-L1 Targeting After Primary Resistance to PD-1 Inhibition in a Patient With a Metastatic Uveal Melanoma. JCO precision oncology 7 (2023)
Helene Salaun, Leanne De Koning, Mathilde Saint-Ghislain, Vincent Servois, Toulsie Ramtohul, Agathe Garcia, Alexandre Matet, Nathalie Cassoux, Pascale Mariani, Sophie Piperno-Neumann, Manuel J Rodrigues
Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patients. Oncoimmunology 11 (1) (2022)
Anne Brédart, Aude Rault, Johanna Terrasson, Etienne Seigneur, Leanne De Koning, Elisabeth Hess, Alexia Savignoni, Paul-Henri Cottu, Jean-Yves Pierga, Sophie Piperno-Neumann, Manuel J Rodrigues, Carole Bouleuc, Sylvie Dolbeault
Helping Patients Communicate With Oncologists When Cancer Treatment Resistance Occurs to Develop, Test, and Implement a Patient Communication Aid: Sequential Collaborative Mixed Methods Study. JMIR research protocols 11 (1) (2022)
Anne Elisabeth Mercier, Renaud Prudent, Michael Sean Pepper, Leanne De Koning, Elsie Magdalena Nolte, Lauralie Peronne, Marcel Nel, Laurence Lafanechère, Annie Margaretha Joubert
Characterization of Signalling Pathways That Link Apoptosis and Autophagy to Cell Death Induced by Estrone Analogues Which Reversibly Depolymerize Microtubules. Molecules (Basel, Switzerland) 26 (3) (2021)
Pierre Verrelle, Didier Meseure, Frédérique Berger, Audrey Forest, Renaud Leclère, André Nicolas, Emilie Fortas, Xavier Sastre-Garau, Marick Lae, Sabah Boudjemaa, Rodrigue Mbagui, Valentin Calugaru, Dalila Labiod, Leanne De Koning, Geneviève Almouzni, Jean-Pierre Quivy
CENP-A Subnuclear Localization Pattern as Marker Predicting Curability by Chemoradiation Therapy for Locally Advanced Head and Neck Cancer Patients. Cancers 13 (16) (2021)
Toulsie Ramtohul, Khadija Ait Rais, Sophie Gardrat, Raymond Barnhill, Sergio Román-Román, Nathalie Cassoux, Manuel J Rodrigues, Pascale Mariani, Leanne De Koning, Gaëlle Pierron, Vincent Servois
Prognostic Implications of MRI Melanin Quantification and Cytogenetic Abnormalities in Liver Metastases of Uveal Melanoma. Cancers 13 (11) (2021)
Adam Byron, Stephan Bernhardt, Bérèngere Ouine, Aurélie Cartier, Kenneth G Macleod, Neil O Carragher, Vonick Sibut, Ulrike Korf, Bryan Serrels, Leanne De Koning
Integrative analysis of multi-platform reverse-phase protein array data for the pharmacodynamic assessment of response to targeted therapies. Scientific reports 10 (1) (2020)
Julia Schueler, Cordula Tschuch, Kerstin Klingner, Daniel Bug, Anne-Lise Peille, Leanne De Koning, Eva Oswald, Hagen Klett, Wolfgang Sommergruber
Induction of Acquired Resistance towards EGFR Inhibitor Gefitinib in a Patient-Derived Xenograft Model of Non-Small Cell Lung Cancer and Subsequent Molecular Characterization. Cells 8 (7) (2019)

Leanne De Koning.css-eqlu8i{font-size:small;padding-left:4px;} (Leanne de Koning)

Publication Activity (10 Years)

Top Topics

Top Venues

Leanne De Koning (Leanne de Koning)